The Olanzapine Injection, cataloged under National Stock Number 6505-01-523-2406, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is American Regent Inc Dba American Regent, Inc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-523-2406 |
| Primary Part Number | NDC00517-0955-01 |
| Item Name | Olanzapine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | American Regent Inc Dba American Regent, Inc |
| Status | ACTIVE |
| General Characteristics Item Description | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC00517-0955-01 PRIMARY | American Regent Inc Dba American Regent, Inc (USA) |
| Reference | Meaning |
|---|---|
| ZYPREXA | 5/1 Secondary reference Eli Lilly and Company |
| 04-1191 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-523-2406 is a Olanzapine Injection, manufactured by American Regent Inc Dba American Regent, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-523-2406 has 1 manufacturer part number on file: NDC00517-0955-01 (American Regent Inc Dba American Regent, Inc).
Key specifications for NDC00517-0955-01: General Characteristics Item Description: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608; Special Features: ACTIVE INGREDIENT AND STRENGTH: OLANZAPINE 10 MG; ADMINISTRATION: INTRAMUSCULAR; USED FOR THE TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA AND BIPOLAR MANIA; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F); PROTECT FROM LIGHT, DO NOT FREEZE; Part Name Assigned by Controlling Agency: OLANZAPINE INJECTION 10MG VIAL. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.